Tag: Patent Litigation

1
Producers of generic medicines and biosimilars even more supported by EU

Producers of generic medicines and biosimilars even more supported by EU

Effective 1 July 2019, the EU adopted a regulation by introducing a supplementary protection certificate (SPC) manufacturing and stockpiling waiver. This waiver also applies for biosimilar versions of SPC-protected medicine during the term of the SPC.

Read More

Copyright © 2019, K&L Gates LLP. All Rights Reserved.